Protagonist Therapeutics, Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 56.4M | 7.4M | 4.7M | 5.5M | 28.3M | 170.6M | 4.7M | 4.2M |
| Cost of Goods Sold | 407K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | 56.0M | 7.4M | 4.7M | 5.5M | 28.3M | 170.6M | 4.7M | 4.2M |
| R&D Expenses | 46.7M | 46.4M | 40.0M | 37.0M | 35.9M | 34.9M | 36.0M | 33.5M |
| Operating Expenses | 59.6M | 57.8M | 51.1M | 47.6M | 47.6M | 43.9M | 46.1M | 43.0M |
| Operating Income | -3.6M | -50.4M | -46.4M | -42.0M | -19.3M | 126.8M | -41.5M | -38.8M |
| Other Income / Gains | 5.9M | 6.6M | 7.1M | 7.4M | 7.7M | 6.9M | 7.8M | 7.5M |
| Net Income | 3.8M | -44.4M | -39.3M | -34.8M | -11.7M | 131.7M | -33.2M | -30.6M |
| EPS (Diluted) | 0.058 | -0.69 | -0.62 | -0.55 | -0.19 | 2.11 | -0.54 | -0.50 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0.993 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| General And Administrative Expenses | 13.3M | 11.4M | 11.1M | 10.6M | 11.7M | 9.0M | 10.2M | 9.4M |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling General And Administrative Expenses | 13.3M | 11.4M | 11.1M | 10.6M | 11.7M | 9.0M | 10.2M | 9.4M |
| Other Expenses | -407K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost And Expenses | 60.0M | 57.8M | 51.1M | 47.6M | 47.6M | 43.9M | 46.1M | 43.0M |
| Interest Income | 5.9M | 6.8M | 7.0M | 7.4M | 7.6M | 6.9M | 7.7M | 7.4M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation And Amortization | 407K | 376K | 361K | 304K | 239K | 536K | 647K | 1.5M |
| Ebitda | -3.2M | -50.0M | -39.0M | -41.7M | -19.1M | 127.3M | -40.8M | -37.3M |
| Ebitdaratio | -0.057 | -6.72 | -8.272 | -7.526 | -0.673 | 0.746 | -8.729 | -8.955 |
| Operating Income Ratio | -0.065 | -6.771 | -9.852 | -7.58 | -0.682 | 0.743 | -8.867 | -9.31 |
| Income Before Tax | 2.3M | -43.7M | -39.3M | -34.6M | -11.7M | 133.7M | -33.6M | -31.3M |
| Income Before Tax Ratio | 0.04 | -5.878 | -8.349 | -6.239 | -0.412 | 0.783 | -7.194 | -7.509 |
| Income Tax Expense | -1.5M | 666K | 0 | 172K | 0 | 2.0M | -420K | -676K |
| Net Income Ratio | 0.067 | -5.968 | -8.349 | -6.27 | -0.412 | 0.772 | -7.104 | -7.347 |
| Epsdiluted | 0.054 | -0.69 | -0.62 | -0.55 | -0.19 | 1.98 | -0.54 | -0.50 |
| Weighted Average Shs Out | 65.1M | 63.6M | 63.8M | 63.5M | 63.0M | 62.3M | 61.8M | 61.3M |
| Weighted Average Shs Out Dil | 70.5M | 63.6M | 63.8M | 63.5M | 63.0M | 66.4M | 61.8M | 61.3M |